Paper5477334
The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.
Beutler E and 1 other. J Lab Clin Med, 1970. Cited by 169 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes. Papers, record 5477334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5477334
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gaucher Disease | Major topic |
| Glucosidases | Major topic |
| Leukocytes | Major topic |
| Adolescent | |
| Adult | |
| Blood Sedimentation | |
| Buffers | |
| Centrifugation | |
| Child | |
| Clinical Enzyme Tests | |
| Female | |
| Heterozygote | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Lymphocytes | |
| Male | |
| Middle Aged | |
| Temperature |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 169 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37176110 | Salmonella Type III Secretion Effector SrfJ: A Glucosylceramidase Affecting the Lipidome and the Transcriptome of Mammalian Host Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37176110 | PubMed |
| 34720832 | A Japanese Patient with Gaucher Disease Treated with the Oral Drug Eliglustat as Substrate Reducing Therapy. | Case Rep Gastroenterol | 2021 | https://conductscience.org/library/papers/34720832 | PubMed |
| 30049986 | The Importance of a Multidisciplinary Approach in the Management of a Patient with Type I Gaucher Disease. | Diseases | 2018 | https://conductscience.org/library/papers/30049986 | PubMed |
| 27083470 | Cellular Uptake of Glucocerebrosidase in Gaucher Patients Receiving Enzyme Replacement Treatment. | Clin Pharmacokinet | 2016 | https://conductscience.org/library/papers/27083470 | PubMed |
| 26345314 | Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease. | Drug Des Devel Ther | 2015 | https://conductscience.org/library/papers/26345314 | PubMed |
| 24575292 | Gaucher's Disease, an Unusual Cause of Massive Splenomegaly, a Case Report. | Iran J Ped Hematol Oncol | 2013 | https://conductscience.org/library/papers/24575292 | PubMed |
| 23430552 | Biochemical and Molecular Chitotriosidase Profiles in Patients with Gaucher Disease Type 1 in Minas Gerais, Brazil: New Mutation in CHIT1 Gene. | JIMD Rep | 2013 | https://conductscience.org/library/papers/23430552 | PubMed |
| 20072680 | Type-3 Gaucher disease with bilateral necrosis of the neck of femur: a case report. | Cases J | 2009 | https://conductscience.org/library/papers/20072680 | PubMed |
| 8301642 | The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme. | J Med Genet | 1993 | https://conductscience.org/library/papers/8301642 | PubMed |
| 8163674 | Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. | J Clin Invest | 1994 | https://conductscience.org/library/papers/8163674 | PubMed |
| 6957882 | Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6957882 | PubMed |
| 6796758 | Beta-glucuronidase deficiency: enzyme studies in an affected family and prenatal diagnosis. | J Inherit Metab Dis | 1980 | https://conductscience.org/library/papers/6796758 | PubMed |
| 6775530 | Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients. | Am J Hum Genet | 1980 | https://conductscience.org/library/papers/6775530 | PubMed |
| 6770675 | Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease. | Am J Hum Genet | 1980 | https://conductscience.org/library/papers/6770675 | PubMed |
| 6436490 | Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency. | J Med Genet | 1984 | https://conductscience.org/library/papers/6436490 | PubMed |
| 4829381 | Esophageal varices in a 60-year-old man with Gaucher's disease. | Am J Dig Dis | 1974 | https://conductscience.org/library/papers/4829381 | PubMed |
| 4354859 | Enzyme loading of erythrocytes. | Proc Natl Acad Sci U S A | 1973 | https://conductscience.org/library/papers/4354859 | PubMed |
| 3852684 | Blood cells as markers for metabolic disorders. | Blut | 1985 | https://conductscience.org/library/papers/3852684 | PubMed |
| 1897529 | High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. | Am J Hum Genet | 1991 | https://conductscience.org/library/papers/1897529 | PubMed |
| 1070017 | Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/1070017 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5477334
GET https://conductscience.org/api/papers/v1/5477334/cited_by?page=2